Lyell Immunopharma (LYEL) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced at 8:00 A.M. Pacific on June 10, 2026, via a virtual platform, with introductions of the Board and executive team.

• Formal business followed the order set in the notice and proxy statement, with three proposals to be presented.

Board and executive committee updates

• Board members and executive team were introduced, including roles such as CFO, COO, General Counsel, and Chief Scientific Officer.

• Representatives from the independent auditor, Broadridge, and outside legal counsel were present and available for questions.

Shareholder proposals

• Three proposals were presented: election of three Class 2 directors, ratification of the independent auditor, and an advisory vote on executive compensation.

• No stockholder nominations for directors were received; nominations were declared closed.